Immune parameters associated with mortality in the elderly are context-dependent: lessons from Sweden, Holland and Belgium
- 168 Downloads
The pioneering Swedish OCTO/NONA-Immune longitudinal studies led by Anders Wikby in Jönköping in the 1990s established a cluster of simple baseline immune parameters associated with excess mortality in 85 year-old non-institutionalized individuals over 2, 4 and 6-year follow-up. We dubbed this cluster the “Immune Risk Profile” (IRP) consisting of poor proliferative responses of peripheral blood mononuclear cells to T cell mitogens, accumulations of CD8+ CD28− T-cells resulting in an inverted CD4:8 ratio, decreased amounts of B-cells, and seropositivity for Cytomegalovirus (CMV). The concept of the IRP has since been applied by others to many different populations in different circumstances and at different ages, but in general without specifically establishing whether the same risk factors were relevant in the tested subjects. However, our own later studies showed that risk factors in aged populations from The Netherlands and Belgium were markedly different, indicating that the IRP cannot simply be transferred between populations. Moreover, there was a striking sex difference in the Belgian study, which was the only one large enough to include sufficient numbers of old men. The reasons for these marked differences between populations which one might have assumed a priori to be quite similar to one another are not clear, and many candidates can be speculated upon, but the important lesson is that there is a marked context-dependency of immune biomarkers of ageing, suggesting that IRPs cannot be assumed to be identical in different populations.
KeywordsImmune risk profile Cytomegalovirus Immunosenescence
The author’s own work was most recently supported by grants from the Deutsche Forschungsgemeinschaft (DFG PA 361/22), the Bundesministerium für Bildung und Forschung (BMBF 16SV5536 K), the European Commission (FP7 LIP F2-2011-259679, IDEAL), and an unrestricted educational grant from the Croeni Foundation.
- Adriaensen W, Derhovanessian E, Vaes B, Van Pottelbergh G, Degryse JM, Pawelec G et al (2015) CD4:8 ratio > 5 is associated with a dominant naive T-cell phenotype and impaired physical functioning in CMV-seropositive very elderly people: results from the BELFRAIL study. J Gerontol A 70(2):143–154. https://doi.org/10.1093/gerona/glu018 CrossRefGoogle Scholar
- Adriaensen W, Pawelec G, Vaes B, Hamprecht K, Derhovanessian E, van Pottelbergh G et al (2017) CD4:8 ratio above 5 is associated with all-cause mortality in CMV-seronegative very old women: results from the BELFRAIL Study. J Gerontol A 72(9):1155–1162. https://doi.org/10.1093/gerona/glw215 CrossRefGoogle Scholar
- Derhovanessian E, Maier AB, Hahnel K, Beck R, de Craen AJ, Slagboom EP et al (2011) Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. J Gen Virol 92(Pt 12):2746–2756. https://doi.org/10.1099/vir.0.036004-0 CrossRefPubMedGoogle Scholar
- Formiga F, Ferrer A, Padros G, Cintra A, Pujol R (2014) Inverted CD4:CD8 ratio is not associated with three-year mortality in a sample of community-dwelling oldest old: the OCTABAIX immune study. J Nutr Health Aging 18(4):425–428. https://doi.org/10.1007/s12603-013-0403-2 CrossRefPubMedGoogle Scholar
- Hadrup SR, Strindhall J, Kollgaard T, Seremet T, Johansson B, Pawelec G et al (2006) Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol. 176(4):2645–2653CrossRefGoogle Scholar
- Spyridopoulos I, Martin-Ruiz C, Hilkens C, Yadegarfar ME, Isaacs J, Jagger C et al (2016) CMV seropositivity and T-cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study. Aging Cell 15(2):389–392. https://doi.org/10.1111/acel.12430 CrossRefPubMedGoogle Scholar
- Strindhall J, Nilsson BO, Lofgren S, Ernerudh J, Pawelec G, Johansson B et al (2007) No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp Gerontol 42(8):753–761. https://doi.org/10.1016/j.exger.2007.05.001 CrossRefPubMedGoogle Scholar
- Thomasini RL, Pereira DS, Pereira FSM, Mateo EC, Mota TN, Guimaraes GG et al (2017) Aged-associated cytomegalovirus and Epstein-Barr virus reactivation and cytomegalovirus relationship with the frailty syndrome in older women. PLoS ONE 12(7):e0180841. https://doi.org/10.1371/journal.pone.0180841 CrossRefPubMedPubMedCentralGoogle Scholar
- Wikby A, Ferguson F, Forsey R, Thompson J, Strindhall J, Lofgren S et al (2005) An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci 60(5):556–565CrossRefGoogle Scholar
- Wikby A, Nilsson BO, Forsey R, Thompson J, Strindhall J, Lofgren S et al (2006) The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech Ageing Dev 127(8):695–704. https://doi.org/10.1016/j.mad.2006.04.003 CrossRefPubMedGoogle Scholar